Description
INTRODUCTION ABOUT FEVASTIN INFUSION
FEVASTIN INFUSION contains Paracetamol which belongs to the group of medicines called Analgesics and Antipyretics. It is used for short-term management of moderate pain (especially after surgery) and fever when administered by the intravenous route is clinically justified.
Before receiving FEVASTIN INFUSION, inform your doctor if you have heart, lung, liver or kidney problems or if you suffer from alcoholism or alcohol abuse, malnourishment and severely low blood volume due to dehydration or blood loss.
FEVASTIN INFUSION should be used with caution in pregnant and breastfeeding women only if clearly advised by the doctor. FEVASTIN INFUSION should be used with caution in children and elderly patients.
The most common side effects of receiving FEVASTIN INFUSION are nausea, vomiting, headache, sleep problems and itching. Inform your doctor if any of these side effect worsens.
USES OF FEVASTIN INFUSION
- For short-term management of moderate pain (especially after surgery) and fever
HOW FEVASTIN INFUSION WORKS
FEVASTIN INFUSION relieves pain by increasing the pain threshold by inhibiting certain enzymes (COX-1 and COX-2) involved in the synthesis of chemicals responsible for inducing pain (prostaglandins). It reduces fever by directly acting on heat-regulating centers in the brain, resulting in vessel relaxation, sweating and loss of body heat.
DIRECTIONS FOR USE
FEVASTIN INFUSION will be given to you only by a doctor or a nurse into the vein as an intravenous infusion. Your doctor will decide the correct dose and duration for you based on your age, body weight and disease condition.
SIDE EFFECTS OF FEVASTIN INFUSION
COMMON
- nausea, vomiting, constipation
- headache
- sleep problems
- itching
RARE
- feeling generally unwell
- drop in blood pressure
- abnormal levels of liver enzymes
Inform your doctor immediately if you experience any of the following side effects while receiving FEVASTIN INFUSION:
- serious allergic reaction or skin rash
Reviews
There are no reviews yet.